Clinical trial
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
NCT00000748
Study timeline
Registry last updated2021-11-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pneumonia, Pneumocystis Cariniiunresolved
HIV Infectionsunresolved
Interventions
Sponsors & collaborators
Glaxo Wellcomecollaborator
Mapped research locations
New YorkNew York, United States2BaltimoreMaryland, United States2DetroitMichigan, United States2AlbuquerqueNew Mexico, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1DenverColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00000748 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.